Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer - the role of clinical response

By Pierga J.-Y.   Mouret E.   Laurence V.   Dieras V.   Savigioni A.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Pouillart P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1089-1096

Elsevier

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 225-227

Informa Healthcare

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 311-312

Informa Healthcare

Access to resources Recommend Favorite

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

By Abrial Sophie   Penault-Llorca Frédérique   Delva Rémi   Bougnoux Philippe   Leduc Bernard   Mouret-Reynier Marie-Ange   Mery-Mignard Dominique   Bleuse Jean-Pierre   Dauplat Jacques   Curé Hervé   Chollet Philippe  

Breast Cancer Research and Treatment, Vol. 94, Iss. 3, 2005-12 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?

By Batsis Charalabos  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1063-1064

Springer Publishing Company

Access to resources Recommend Favorite